Get started
INNOCAN PHARMA CORPORATIONINNOCAN PHARMA CORPORATIONINNOCAN PHARMA CORPORATION

INNOCAN PHARMA CORPORATION

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

INNO chart


Full chart

Key stats


Market capitalization
‪60.26 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.015 CAD
Net income (FY)
‪−6.34 M‬ CAD
Revenue (FY)
‪18.43 M‬ CAD
Shares float
‪220.47 M‬
Beta (1Y)
0.69

Employees


Employees (FY)
9
Revenue / Employee (1Y)
‪2.05 M‬ CAD
Net income / Employee (1Y)
‪−704.84 K‬ CAD

About INNOCAN PHARMA CORPORATION


Sector
Health Technology
CEO
Iris Or Gabi Bincovich
Headquarters
Calgary
Website
innocanpharma.com
Founded
2018
FIGI
BBG00PBK8GX7
InnoCan Pharma Corp. operates as a pharmaceutical tech company. Its segments include: Pharmaceuticals and Consumer Wellness. The Pharmaceuticals segment focuses on developing innovative drug delivery platform technologies based on advanced cannabinoids science. It involves two drug delivery technologies: LPT CBD- loaded liposome platform and CLX CBD-loaded exosomes platform. The Consumer Wellness segment develops and markets a wide portfolio of innovative and self-care products to promote a healthier lifestyle. The company was founded in October 2017 and is headquartered in Alberta, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

INNO news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of INNO is 0.195 CAD — it has decreased by −7.14% in the past 24 hours. Watch INNOCAN PHARMA CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange INNOCAN PHARMA CORPORATION stocks are traded under the ticker INNO.
INNO stock has risen by 2.63% compared to the previous week, the month change is a −15.22% fall, over the last year INNOCAN PHARMA CORPORATION has showed a −37.10% decrease.
INNO reached its all-time high on Sep 16, 2021 with the price of 1.650 CAD, and its all-time low was 0.050 CAD and was reached on Mar 19, 2020. View more price dynamics on INNO chart.
See other stocks reaching their highest and lowest prices.
INNO stock is 7.69% volatile and has beta coefficient of 0.69. Track INNOCAN PHARMA CORPORATION stock price on the chart and check out the list of the most volatile stocks — is INNOCAN PHARMA CORPORATION there?
Today INNOCAN PHARMA CORPORATION has the market capitalization of ‪55.95 M‬, it has increased by 13.51% over the last week.
Yes, you can track INNOCAN PHARMA CORPORATION financials in yearly and quarterly reports right on TradingView.
INNO net income for the last quarter is ‪−395.55 K‬ CAD, while the quarter before that showed ‪461.11 K‬ CAD of net income which accounts for −185.78% change. Track more INNOCAN PHARMA CORPORATION financial stats to get the full picture.
No, INNO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 29, 2024, the company has 9.00 employees. See our rating of the largest employees — is INNOCAN PHARMA CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOCAN PHARMA CORPORATION EBITDA is ‪−1.59 M‬ CAD, and current EBITDA margin is −27.60%. See more stats in INNOCAN PHARMA CORPORATION financial statements.
Like other stocks, INNO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOCAN PHARMA CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOCAN PHARMA CORPORATION technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOCAN PHARMA CORPORATION stock shows the strong sell signal. See more of INNOCAN PHARMA CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.